US Pre-Market TL;DR 5 in Five:
On September 1st, global equity markets declined, with the DAX (-3.8%) and Nasdaq 100 (-1.3%) notably lower. Geopolitical tensions, rising European inflation, and upcoming US labor data fueled the downturn, increasing expectations for central bank tightening.
1️⃣ NVS: +5.5%
Novartis AG shares rose in pre-market trading following positive Phase III trial results for remibrutinib in treating relapsing multiple sclerosis.
2️⃣ UBS: -3.6%
UBS Group AG shares declined due to regulatory concerns and uncertainties surrounding proposed stricter capital rules in Switzerland.
3️⃣ MDT: +4.1%
Medtronic PLC shares traded sharply higher after reporting stronger-than-expected first-quarter earnings and raising its fiscal year revenue guidance.
4️⃣ RDHL: -9.8%
Redhill Biopharma Ltd shares dropped significantly despite acquiring commercialization rights to new gastrointestinal drugs.
5️⃣ MSTR: -3.3%
Strategy Inc shares moved lower amid intensified bearish sentiment and criticism regarding its strategy of selling stock to acquire Bitcoin.
—
✨ Share this link to invite friends: on.skr.ma/jointldr
👉🏻 Insights about to go viral: on.skr.ma/viral
September 1, 2026 101
